Five core targets, AKT1, EGFR, HSP90AA1, SRC, and STAT3, were identified as key mediators of its anti-lung cancer action, participating in critical signaling pathways including MAPK, PI3K-Akt, and Ras pathways. This evidence concerns the gene EGFR and lung carcinoma.